The cardiovascular metabolic syndrome

Thesis

Cover

Titlepage

Contents

1 Cardiovascular Metabolic Syndrome - an Interplay of Obesity, Inflammation, Diabetes and Coronary Heart Disease

Part I Obesity

2 Obesity and the Risk of Mortality Following Acute Myocardial Infarction

3 Obesity and Clinical Restenosis after Coronary Stent Placement

Part II Type 2 Diabetes

4 Effect of Diabetes Mellitus and its Treatment on Ventricular Arrhythmias Complicating Acute Myocardial Infarction

5 Circadian Variation in the Onset of Myocardial Infarction: Effect of Duration of Diabetes Mellitus

Part III Inflammation

6 Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women

7 -455 G/A Polymorphism and Preprocedural Plasma Levels of Fibrinogen Show No Association with the Risk of Clinical Restenosis in Patients with Coronary Stent Placement

8 Pre-procedural Levels of Erythrocyte Sedimentation Rate (ESR) and Risk of Clinical Restenosis in Patients with Percutaneous Coronary Intervention and Coronary Stent Placement

Part IV Lipids

9 Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention

Part V Metabolic Syndrome

10 Increased Level of Cardio-Respiratory Fitness Blunts the Inflammatory Response in Metabolic Syndrome

11 Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention

12 Metabolic Syndrome and Risk of Coronary, Cerebral and Peripheral Vascular Disease in a Large Dutch Population with Familial Hypercholesterolemia

Summary

Samenvatting

Publications

Acknowledgements

Curriculum Vitae

Cover